Fundz

Governments Of Ontario And Canada Invest In Microbix

PRIVATEMar 20, 2023

Round Type

Funding Round

MississaugaManufacturingBiotechnologyHealth Care

Description

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is undertaking further expansions to its capabilities and capacity for manufacturing specialized products relating to diagnostic testing for infectious diseases. The Government of Ontario is supporting the expansions at Microbix’s three adjacent sites in Mississauga with a grant of $ 840,000 from the Ontario Together Fund (“OTF”). A separate $ 840,000 of interest-free loan funding has also been provided by the Government of Canada through its FedDev Ontario program

Quick answer

Microbix Biosystems Inc. raised an undisclosed amount in a Funding Round round, dated March 20, 2023. Microbix Biosystems Inc. is based in Mississauga, Ontario, Canada.

How much did Microbix Biosystems Inc. raise?
Microbix Biosystems Inc. raised an undisclosed amount in a Funding Round round on March 20, 2023.
What does Microbix Biosystems Inc. do?
Microbix creates proprietary biological products for human health, with over 100 skilled employees and annualized sales targeting C$ 2.0 million per month.
Where is Microbix Biosystems Inc. based and how big is it?
Microbix Biosystems Inc. is based in Mississauga, Ontario, Canada.
Who are the decision-makers at Microbix Biosystems Inc?
Fundz holds 1 contact at Microbix Biosystems Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Microbix Biosystems Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Novabay raised $3M (Seed) on May 1, 2023.
  • Shape Memory Medical raised $4.8M (Seed) on April 24, 2023.
  • MedShift raised $108M (Funding Round) on April 20, 2023.
  • Persist AI raised $4.9M (Seed) on April 13, 2023.
  • Amend Surgical raised an undisclosed amount (Funding Round) on April 11, 2023.
  • Phlow raised $35M (Series B) on April 5, 2023.

Who to call at Microbix Biosystems Inc., and when

A new round usually means Microbix Biosystems Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Microbix Biosystems Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Microbix Biosystems Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Microbix Biosystems Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Microbix Biosystems Inc.

Location

265 WATLINE AVENUE

Mississauga, Ontario, Canada

About

Microbix creates proprietary biological products for human health, with over 100 skilled employees and annualized sales targeting C$ 2.0 million per month. It makes a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs are sold to clinical laboratory accreditation organizations, diagnostics companies, and clinical laboratories. Microbix QAPs are now available in over 30 countries, distributed by 1WA (Oneworld Accuracy Inc.), Alpha-Tec Systems, Inc., Diagnostic International Distribution SpA., Labquality Oy, The Medical Supply Company of Ireland, Neo-Science Equipment LLC, R-Biopharm AG, SDT Molecular Pte Ltd, Seegene Canada Inc., and Thomas Scientific LLC. Microbix is ISO 9001 and 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE marked products. Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably viral transport medium (DxTM™) to stabilize patient samples for lab-based molecular diagnostic testing and Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix is traded on the TSX and OTCQX, and headquartered in Mississauga, Ontario, Canada.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Microbix Biosystems Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJoseph R., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Microbix Biosystems Inc.'s next move

See what Strategic adds

Microbix Biosystems Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.